EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

ANTIHYPERTENSIVE POTENTIAL OF ORTHOSIPHON STAMINEUS COMPOUNDS TARGETING ANGIOTENSIN-CONVERTING ENZYME AND L-TYPE CALCIUM CHANNELS: A MOLECULAR DOCKING STUDY

Reza Alrayan, Ismanurrahman Hadi, Rizka Islamia Bashori, Andrian Hoerul Anwar, Khairun Nisa, Cut Fatia Ulfa, Friska Aprianti, Yusnita, Arshy Prodyanatasari

Medical Sains : Jurnal Ilmiah Kefarmasian · 31.03.2026 · 11 (1) · 121-130

DOI: 10.37874/ms.v11i1.1992 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sains : Jurnal Ilmiah Kefarmasian, online erschienen am 31.03.2026. Verfasst von Reza Alrayan und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension is a major cardiovascular disease that significantly contributes to global morbidity and mortality. Inhibition of Angiotensin-Converting Enzyme (ACE) and modulation of L-type calcium channels (Cav1.3) are two critical targets in antihypertensive therapy. This study aimed to explore the antihypertensive potential of bioactive compounds from Orthosiphon stamineus using an in silico approach. Molecular docking was performed against ACE (PDB ID: 7Q26) and Cav1.3 (PDB ID: 8E59), and their pharmacokinetic and toxicity profiles were evaluated. Molecular docking was performed using AutoDock Vina within the PyRx software, and ligand–protein interactions were analyzed using the Biovia Discovery Studio Visualizer. The ADMET properties were predicted using pkCSM. The results indicated that most compounds, particularly flavonoids such as sinensetin, eupatorin, and 3?-hydroxy-5,6,7,4?-tetramethoxyflavone, met the drug-likeness criteria, exhibited high intestinal absorption, and demonstrated favorable safety profiles. Docking analysis revealed stable hydrogen bonds and hydrophobic interactions with key residues in both protein targets. Overall, these findings suggest that bioactive compounds from Orthosiphon stamineus have potential as antihypertensive candidates through ACE inhibition and Cav1.3 modulation. However, further in vitro and in vivo studies are required to confirm the efficacy and safety of these compounds. Keywords: Hypertension; Orthosiphon stamineus; ACE inhibitor; Cav1.3; Molecular docking; In silico

Zitieren

APA

Alrayan, R., Hadi, I., Bashori, R. I., Anwar, A. H., Nisa, K., Ulfa, C. F., Aprianti, F., Yusnita, & Prodyanatasari, A. (2026). ANTIHYPERTENSIVE POTENTIAL OF ORTHOSIPHON STAMINEUS COMPOUNDS TARGETING ANGIOTENSIN-CONVERTING ENZYME AND L-TYPE CALCIUM CHANNELS: A MOLECULAR DOCKING STUDY. Medical Sains : Jurnal Ilmiah Kefarmasian, 11(1), 121-130. https://doi.org/10.37874/ms.v11i1.1992

Vancouver

Alrayan R, Hadi I, Bashori RI, Anwar AH, Nisa K, Ulfa CF, et al. ANTIHYPERTENSIVE POTENTIAL OF ORTHOSIPHON STAMINEUS COMPOUNDS TARGETING ANGIOTENSIN-CONVERTING ENZYME AND L-TYPE CALCIUM CHANNELS: A MOLECULAR DOCKING STUDY. Medical Sains : Jurnal Ilmiah Kefarmasian. 2026;11(1):121-130. doi:10.37874/ms.v11i1.1992

BibTeX
@article{Alrayan2026,
  author = {Alrayan, Reza and Hadi, Ismanurrahman and Bashori, Rizka Islamia and Anwar, Andrian Hoerul and Nisa, Khairun and Ulfa, Cut Fatia and Aprianti, Friska and Yusnita and Prodyanatasari, Arshy},
  title = {ANTIHYPERTENSIVE POTENTIAL OF ORTHOSIPHON STAMINEUS COMPOUNDS TARGETING ANGIOTENSIN-CONVERTING ENZYME AND L-TYPE CALCIUM CHANNELS: A MOLECULAR DOCKING STUDY},
  journal = {Medical Sains : Jurnal Ilmiah Kefarmasian},
  year = {2026},
  volume = {11},
  number = {1},
  pages = {121--130},
  doi = {10.37874/ms.v11i1.1992}
}
Kostenlos starten →